NN1250

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

30 regulatory and trial events tracked for NN1250, covering 2013-11-27 to 2017-10-09. Get the full timeline:

Most recent: Clinical Trial Update: A Trial Evaluating the Effect of NN1250 at Steady State Conditions in Subjects With Type 1 Diabetes [Phase 1]